Appointment of Joint Corporate Brokers

PRESS RELEASE

Appointment of Joint Corporate Brokers

READING, UNITED KINGDOM (16 January 2017) - ConvaTec Group Plc ("the Company"), a leading global medical products and technologies company, is pleased to announce the appointment of Goldman Sachs International and UBS Investment Bank as the Company's joint corporate brokers, with immediate effect.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com.

Enquiries

Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226

Rebecca Fitchett, Finsbury +44 (0)207 251 3801

Goldman Sachs International +44 (0)20 7774 1000

William Smiley

Phil Raper

UBS Investment Bank +44 (0)20 7567 8000

Craig Calvert

Christopher Smith